share_log

HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $7

Moomoo 24/7 ·  Apr 17 05:52

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $8 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment